Dose based on m² [General Sta­tis­tics]

posted by Dr_Dan  – Germany, 2013-07-17 13:09 (4715 d 07:14 ago) – Posting: # 10993
Views: 11,400

Dear VK
What do you mean by "We did regular calculations"? In a cross-over study BE is based on the intra-individual comparison of test and reference and therefore it is theoretically possible to administer different doses (dose adjusted PK parameters). However, I guess in your case you administered a combination of different strengths (=different products), right?
For example:
70% received 1x100mg
30% received either 1x50mg+1x25mg or 1x100mg+1x25mg
Then indeed only 70% of the subjects could be evaluated since a pure comparison is only possible between your 100 mg product and the originator.
If you had choosen
70% received 4x25mg
30% received either 3x25mg or 5x25mg
Then 100% of the subjects could be evaluated.
Kind regards
Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
112 visitors (0 registered, 112 guests [including 16 identified bots]).
Forum time: 20:23 CEST (Europe/Vienna)

I have never in my life learned anything
from any man who agreed with me.    Dudley Field Malone

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5